Name: Jeremy Farrar on the global race for a Covid-19 vaccine | FT Interview
Uploaded: 2021-05-23T16:06:35.000Z
Duration: 20 min 29 s
Description: VoiceTubeの動画で発音を聞きながら英語表現を覚えよう！学べる英語：

様態の副詞

It's widely accepted that a vaccine is the only way

And there are various estimates of the number of vaccine

The London School of Hygiene and Tropical Medicine

has put this figure at 183, and other estimates

Of all the vaccine projects that are currently in development,

can you give a sense of how many of these have actually

gone to human trial and you think are viable?

Whether there's 183 or over 200, it's a big number.

And that's a very good thing because we don't know

We don't have any other vaccine for a human virus

We don't have vaccines for Sars 1 as or Mers or indeed yet Sars

So it is important that there's a diverse portfolio

Of those 20 lead candidates I'm aware of probably about 10

phase 1, phase 2 trials around the world, from China

And it, of course, depends what you mean by success.

But I think if you said each individual one at the moment

maybe has a 10 per cent to 15 per cent chance of success,

maybe 20 per cent with the more advanced ones, that's

Even with the number of vaccine projects in development,

is it the case that most of the money that governments

are investing are actually just going to a handful of these

Globally, there's investment in all of these 200,

And it is absolutely crucial there's a broad portfolio

because we don't yet know which vaccine is going to work.

Yes, the lead candidates have had more funding.

But that's a good thing because it allows

But what is important is that we don't just

back one vaccine or two vaccines because they may fail.

we back a whole portfolio of these vaccines,

including disruptive ways of making vaccines

- RNA or DNA technology or other technologies which

we haven't used before in vaccine developments.

The danger will be that countries back one or two

with all of their resources, and those one or two don't work.

And then those countries that do that will

And what about the production and distribution challenges?

So once we hopefully actually get a vaccine.

I mean, you have pharmaceutical companies now warning

Can you give a sense of what our production and distribution

to what it will need to be to do something that's

never been done, to vaccinate the entire global population?

Over time we will need to vaccinate very large percent...

parts of the population of the world's 7bn people.

But to begin with we would have to target those

Healthcare workers, the elderly, people from other backgrounds

Having a vaccine that can be offered to 1,000 people

If we're going to really have the exit strategy

we're going to have to be able to vaccinate very large numbers

It means doing the research and development.

But critically, in parallel, rather than in sequence,

it means making sure we can turn that vaccine

And that means thinking about things in a very different way

It means thinking in parallel, not in sequence.

It means thinking now, if I had 200m doses of a vaccine could

字幕リスト動画再生

Jeremy Farrar on the global race for a Covid-19 vaccine | FT Interview

absolutely

individual

inevitable

pandemic